SCHEMBL6138031

SCHEMBL6138031

COc1ccc(C(=O)N(CCCN(C)C)C(=N)N)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
PARP10 Q53GL7 2/20 0.45
PRSS1 P07477 1/20 0.45
PRSS2 P07478 1/20 0.45
PRSS3 P35030 1/20 0.45
PARP1 P09874 1/20 0.45
PARP2 Q9UGN5 1/20 0.45
PARP4 Q9UKK3 1/20 0.45
KMT2A Q03164 5/20 0.44
MEN1 O00255 3/20 0.44
NPC1 O15118 1/20 0.44
DRD2 P14416 1/20 0.44
POLB P06746 1/20 0.42
CYP2D6 P10635 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
UTS2R Q9UKP6 1/20 0.41
SIRT2 Q8IXJ6 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8767719 0.86 CA1 (0.45) CA1CA2PARP10PRSS1PRSS2
SCHEMBL6138068 0.85 NPC1 (0.39) CA2KMT2ANPC1POLBHTT
SCHEMBL6003647 0.81 LPAR1 (0.53) KMT2AMEN1NPC1HTTKDM4E
SCHEMBL14175138 0.80 DRD2 (0.61) CA1CA2KMT2AMEN1NPC1
SCHEMBL6137598 0.78 DRD2 (0.53) PARP10KMT2AMEN1NPC1DRD2
SCHEMBL6137828 0.76 ACHE (0.56) KMT2AMEN1NPC1HTTSMN1; SMN2
SCHEMBL11220850 0.73 CA1 (0.52) CA1CA2PARP10PARP1PARP2
SCHEMBL17033395 0.72 PDE4B (0.66) KMT2ANPC1SIRT2ALDH1A1
SCHEMBL6137845 0.71 L3MBTL1 (0.52) PARP10KMT2AMEN1NPC1POLB
SCHEMBL6137921 0.71 KDM4E (0.45) CA1CA2PARP10PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1032556-A4 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-02 EP claimed
EP-1032556-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-09-06 EP claimed
WO-1999020599-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-04-29 WO claimed